BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kostoff RN, Kanduc D, Porter AL, Shoenfeld Y, Calina D, Briggs MB, Spandidos DA, Tsatsakis A. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety. Toxicol Rep 2020;7:1448-58. [PMID: 33110761 DOI: 10.1016/j.toxrep.2020.10.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Iqbal MJ, Javed Z, Herrera-bravo J, Sadia H, Anum F, Raza S, Tahir A, Shahwani MN, Sharifi-rad J, Calina D, Cho WC. Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation. Cancer Cell Int 2022;22:354. [DOI: 10.1186/s12935-022-02777-7] [Reference Citation Analysis]
2 Kostoff RN, Briggs MB, Kanduc D, Dewanjee S, Kandimalla R, Shoenfeld Y, Porter AL, Tsatsakis A. Modifiable contributing factors to COVID-19: A comprehensive review. Food and Chemical Toxicology 2022. [DOI: 10.1016/j.fct.2022.113511] [Reference Citation Analysis]
3 Deruelle F. The pharmaceutical industry is dangerous to health. Further proof with COVID-19. Surgical Neurology International 2022;13:475. [DOI: 10.25259/sni_377_2022] [Reference Citation Analysis]
4 Gargouri MA, Yousfi N, Toutain J, Farès S, Lejoyeux R, Gabison E, Cochereau I, Titah C, Azar G. Multiple Evanescent White Dot Syndrome Following COVID-19 mRNA Vaccination. Ocul Immunol Inflamm 2022;:1-5. [PMID: 36228041 DOI: 10.1080/09273948.2022.2127782] [Reference Citation Analysis]
5 Sharifi-rad J, Rapposelli S, Sestito S, Herrera-bravo J, Arancibia-diaz A, Salazar LA, Yeskaliyeva B, Beyatli A, Leyva-gómez G, González-contreras C, Gürer ES, Martorell M, Calina D. Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation. JPM 2022;12:1515. [DOI: 10.3390/jpm12091515] [Reference Citation Analysis]
6 Ameratunga R. SARS-CoV-2 the ASIA virus (autoimmune/autoinflammatory syndrome induced by adjuvants), the risk of infertility and vaccine hesitancy. Expert Rev Vaccines 2022. [PMID: 35695410 DOI: 10.1080/14760584.2022.2089120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Baby B, Vilson A, Aranjani J, Eespintakath S, Sudheer A, Mathew S, Nair V, Joseph S. Assessment of fear among the general public of Kerala, India, following a surge of COVID‑19 cases. Med Int 2022;2:9. [DOI: 10.3892/mi.2022.34] [Reference Citation Analysis]
8 Lerner A, Benzvi C. Checkpoint Inhibitors and Induction of Celiac Disease-like Condition. Biomedicines 2022;10:609. [DOI: 10.3390/biomedicines10030609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Efstathiou V, Stefanou MI, Siafakas N, Makris M, Tsivgoulis G, Zoumpourlis V, Spandidos DA, Smyrnis N, Rizos E. Suicidality and COVID-19: Suicidal ideation, suicidal behaviors and completed suicides amidst the COVID-19 pandemic (Review). Exp Ther Med 2022;23:107. [PMID: 34976149 DOI: 10.3892/etm.2021.11030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
10 Mohseni Afshar Z, Babazadeh A, Janbakhsh A, Afsharian M, Ebrahimpour S. COVID-19 vaccines: challenges and solutions. Minerva Respir Med 2022;60. [DOI: 10.23736/s2784-8477.21.01921-0] [Reference Citation Analysis]
11 Lak E, Mohammadi MJ, Yousefi H. Impact of COVID-19 acute respiratory disease on the risk factors attributed to cancer patients. Toxicol Rep 2022;9:46-52. [PMID: 34934636 DOI: 10.1016/j.toxrep.2021.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Hurford JE. COVID-19 and Compulsory Vaccination: An Acceptable Form of Coercion? New Bioeth 2021;:1-23. [PMID: 34906027 DOI: 10.1080/20502877.2021.2010441] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Nash C. Challenges to Learners in Interpreting Self as Other, Post COVID-19. Challenges 2021;12:31. [DOI: 10.3390/challe12020031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Papakonstantinou E, Dragoumani K, Efthimiadou A, Palaiogeorgou AM, Pierouli K, Mitsis T, Chrousos GP, Bacopoulou F, Vlachakis D. Haematological malignancies implications during the times of the COVID-19 pandemic. Oncol Lett 2021;22:856. [PMID: 34777590 DOI: 10.3892/ol.2021.13117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Drakoulis N, Porter AL, Tsatsakis A, Spandidos DA. Contributing factors common to COVID‑19 and gastrointestinal cancer. Oncol Rep 2022;47:16. [PMID: 34779496 DOI: 10.3892/or.2021.8227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Koh JS, Hoe RHM, Yong MH, Chiew HJ, Goh Y, Yong KP, Tu TM, Chan DWS, Tan BY, Yeo LLL, Quek AML, Siow I, Saini M, Angon J, Rathakrishnan S, Chen GJ, Hui AC, Ahmad A, Shwe MP, Tan K, Seet RCS, Cai M, Kuo SM, Foo LL, Umapathi T. Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines. J Neurol Sci 2021;430:120030. [PMID: 34688190 DOI: 10.1016/j.jns.2021.120030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
17 Kostoff RN, Calina D, Kanduc D, Briggs MB, Vlachoyiannopoulos P, Svistunov AA, Tsatsakis A. Why are we vaccinating children against COVID-19? Toxicol Rep 2021;8:1665-84. [PMID: 34540594 DOI: 10.1016/j.toxrep.2021.08.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
18 Tsatsakis A, Vakonaki E, Tzatzarakis M, Flamourakis M, Nikolouzakis TK, Poulas K, Papazoglou G, Hatzidaki E, Papanikolaou NC, Drakoulis N, Iliaki E, Goulielmos GN, Kallionakis M, Lazopoulos G, Kteniadakis S, Alegkakis A, Farsalinos K, Spandidos DA. Immune response (IgG) following full inoculation with BNT162b2 COVID‑19 mRNA among healthcare professionals. Int J Mol Med 2021;48:200. [PMID: 34515322 DOI: 10.3892/ijmm.2021.5033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
19 Sharifi-Rad J, Quispe C, Rahavian A, Pereira Carneiro JN, Rocha JE, Alves Borges Leal AL, Bezerra Morais Braga MF, Melo Coutinho HD, Ansari Djafari A, Alarcón-Zapata P, Martorell M, Antika G, Tumer TB, Cruz-Martins N, Helon P, Paprocka P, Koch W, Docea AO, Calina D. Bioactive Compounds as Potential Agents for Sexually Transmitted Diseases Management: A Review to Explore Molecular Mechanisms of Action. Front Pharmacol 2021;12:674682. [PMID: 34504422 DOI: 10.3389/fphar.2021.674682] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
20 Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Vardavas AI, Porter AL. Common contributing factors to COVID-19 and inflammatory bowel disease. Toxicol Rep 2021;8:1616-37. [PMID: 34485092 DOI: 10.1016/j.toxrep.2021.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Calina D, Hernández AF, Hartung T, Egorov AM, Izotov BN, Nikolouzakis TK, Tsatsakis A, Vlachoyiannopoulos PG, Docea AO. Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2. Life (Basel) 2021;11:907. [PMID: 34575056 DOI: 10.3390/life11090907] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
22 Patrignani A, Schicchi N, Calcagnoli F, Falchetti E, Ciampani N, Argalia G, Mariani A. Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiol Case Rep 2021;16:3321-5. [PMID: 34367386 DOI: 10.1016/j.radcr.2021.07.082] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
23 Paul E, Brown GW, Kalk A, Ridde V. Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager. Vaccine 2021;39:4921-4. [PMID: 34315610 DOI: 10.1016/j.vaccine.2021.07.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
24 Hernández AF, Calina D, Poulas K, Docea AO, Tsatsakis AM. Safety of COVID-19 vaccines administered in the EU: Should we be concerned? Toxicol Rep 2021;8:871-9. [PMID: 33898273 DOI: 10.1016/j.toxrep.2021.04.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 51.0] [Reference Citation Analysis]
25 Vinceti M, Filippini T, Rothman KJ, Di Federico S, Orsini N. SARS-CoV-2 infection incidence during the first and second COVID-19 waves in Italy. Environ Res 2021;197:111097. [PMID: 33811866 DOI: 10.1016/j.envres.2021.111097] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 18.0] [Reference Citation Analysis]
26 Neagu M, Calina D, Docea AO, Constantin C, Filippini T, Vinceti M, Drakoulis N, Poulas K, Nikolouzakis TK, Spandidos DA, Tsatsakis A. Back to basics in COVID-19: Antigens and antibodies-Completing the puzzle. J Cell Mol Med 2021;25:4523-33. [PMID: 33734600 DOI: 10.1111/jcmm.16462] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 22.0] [Reference Citation Analysis]
27 Calina D, Hartung T, Mardare I, Mitroi M, Poulas K, Tsatsakis A, Rogoveanu I, Docea AO. COVID-19 pandemic and alcohol consumption: Impacts and interconnections. Toxicol Rep 2021;8:529-35. [PMID: 33723508 DOI: 10.1016/j.toxrep.2021.03.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 47.0] [Reference Citation Analysis]
28 Doulberis M, Papaefthymiou A, Kotronis G, Gialamprinou D, Soteriades ES, Kyriakopoulos A, Chatzimichael E, Kafafyllidou K, Liatsos C, Chatzistefanou I, Anagnostis P, Semenin V, Ntona S, Gkolia I, Papazoglou DD, Tsinonis N, Papamichos S, Kirbas H, Zikos P, Niafas D, Kountouras J. Does COVID-19 Vaccination Warrant the Classical Principle "ofelein i mi vlaptin"? Medicina (Kaunas) 2021;57:253. [PMID: 33803295 DOI: 10.3390/medicina57030253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
29 Katopodis P, Kerslake R, Davies J, Randeva HS, Chatha K, Hall M, Spandidos DA, Anikin V, Polychronis A, Robertus JL, Kyrou I, Karteris E. COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease. Int J Mol Med 2021;47:64. [PMID: 33649798 DOI: 10.3892/ijmm.2021.4897] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
30 Siddiqui R, Mungroo MR, Khan NA. SARS-CoV-2 invasion of the central nervous: a brief review. Hosp Pract (1995) 2021;49:157-63. [PMID: 33554684 DOI: 10.1080/21548331.2021.1887677] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
31 Talotta R. Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to "potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases". Clin Immunol 2021;224:108665. [PMID: 33429060 DOI: 10.1016/j.clim.2021.108665] [Cited by in Crossref: 97] [Cited by in F6Publishing: 105] [Article Influence: 97.0] [Reference Citation Analysis]
32 Kostoff RN, Briggs MB, Porter AL. Toxicology issues related to the COVID–19 outbreak. Toxicological Risk Assessment and Multi-System Health Impacts from Exposure 2021. [DOI: 10.1016/b978-0-323-85215-9.00017-9] [Reference Citation Analysis]
33 Alexandris N, Lagoumintzis G, Chasapis CT, Leonidas DD, Papadopoulos GE, Tzartos SJ, Tsatsakis A, Eliopoulos E, Poulas K, Farsalinos K. Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions. Toxicol Rep 2021;8:73-83. [PMID: 33425684 DOI: 10.1016/j.toxrep.2020.12.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]